Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 345.6M | $ 151.66M | 43.88% |
3/31/2025 | $ 310.19M | $ 125.71M | 40.53% |
12/31/2024 | $ 220.67M | $ 97M | 43.96% |
9/30/2024 | $ 207.14M | $ 108.4M | 52.33% |
6/30/2024 | $ 220.2M | $ 109.17M | 49.58% |
3/31/2024 | $ 225.48M | $ 121.66M | 53.96% |
12/31/2023 | $ 241.7M | $ 120.47M | 49.84% |
9/30/2023 | $ 235M | $ 141.16M | 60.07% |
6/30/2023 | $ 253.71M | $ 128.14M | 50.5% |
3/31/2023 | $ 276.86M | $ 198.09M | 71.55% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for AKEBIA THERAPEUTICS INC is calculated as follows: GP [ $ 37.34M ] / Assets [ $ 676.14M ]
(=) GPA [ 5.52% ]
Minimum
Mar 31, 2021
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.14K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.34% |
std | 19.95% |